Leading dealmakers understand that the challenge is not just to find a partner, but the right partner — one who will contribute to investor confidence and long-term success, more than immediate capital.
If you don't know what's out there, you're taking on risk while leaving money on the table, or you're not getting a deal done.
The complexity and duration of a drug licensing deal makes partnerships more like marriages — there’s nothing better than finding the right relationship, and nothing worse than being trapped in the wrong one. Finding the right long-term partner requires a methodical evaluation process that goes deep in examining strategic synergies with mid-to-large companies.
Who within the potential partner company is likely to get excited about this deal? Accessing potential partners through an internal champion ensures a shortened “sales” cycle.
Today, 60% of life-sciences pipelines are in-licensed. Demand for innovative products is high. As an out-licensor, it’s on you to drive interest in your product while angling towards the best long-term partnership for your company.
MotionHall’s Outmatch uses a proprietary partnering algorithm modelled after the thought patterns of leading dealmakers, and combines this with machine power to assess terabytes of deep industry data to match your deal.
With OutMatch, you can address critical questions upfront, eliminate fruitless discussions and tailor information to speak to your value prop in addressing your prospective partner’s needs.
Be first to receive new white papers, industry intelligence and product announcements.